当前位置：首页 > 文献互助 > 互助详情

… -blind, placebo-controlled single and multipleascending dose study of amg 133 in subjects with obesity: Late breaking: A phase 1 study of amg 133 in subjects with …复制

用户aKgJC6g3RnhA 2个月前 76 10 已关闭

DOI:复制

文献链接:复制

其他信息:

JL Strande, V Kurra, R Jeswani…
Metabolism …, 2023
metabolismjournal.com
… AMG 133 is a glucose-dependent insulinotropic polypeptide antagonist antibody … AMG 133 had acceptable safety and tolerability profiles. This along with the pharmacokinetics …

上一篇：Cold snare endoscopic mucosal resection versus standard hot technique for large flat nonpedunculated colonic lesions: a randomized controlled trial

下一篇：Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides

互助时间线

2025-04-29 14:34:18 [关闭求助]

楼主用户aKgJC6g3RnhA关闭了求助

2025-04-28 11:40:10 [发起求助]

最新发布的求助

Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways 24分钟前
Reduced Achilles tendon stiffness in aging associates with higher metabolic cost of walking 54分钟前
Knee Plical Pathology and Impingement Syndromes 59分钟前
Human trial of vaginal microbiome transplantation 1小时前
The Biomechanical, Biochemical, and Morphological Properties of 19 Human Cadaveric Lower Limb Tendons and Ligaments: An Open-Access Data Set 1小时前
The Art of Finding the Right Drug Target: Emerging Methods and Strategies 1小时前
Pathological perturbations in diabetic retinopathy: hyperglycemia, AGEs, oxidative stress and inflammatory pathways 2小时前
Adverse event profiles of four monomethyl auristatin E-conjugated antibody drug conjugates: a disproportionality analysis based on the US FDA adverse event reporting system (FAERS) database 2小时前
Folate 2小时前
A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled‐Release Formulations Versus a Marketed Orlistat Product 2小时前
A placebo controlled, randomised, double-blind, 4 way cross-over study of 3 doses of EVT201 (2.5 mg, 5mg and 10mg) on aspects of sleep and morning after … 2小时前
In vitro and in vivo ADME of heterobifunctional degraders: a tailored approach to optimize DMPK properties of PROTACs© 5小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com